Zanidatamab (ZW25) is a humanised bispecific monoclonal antibody that simultaneously targets two distinct HER2 epitopes located on ECD2 and ECD4, thereby enhancing receptor clustering and signaling blockade, Zanidatamab exhibits strong anti-tumour activity, supporting its application in HER2-positive cancer research and antibody-based therapeutic development.
Purity:
95.00%
CAS Number:
[2169946-15-8]
Target:
HER
* VAT and and shipping costs not included. Errors and price changes excepted